Skip to main content
2024-issue-3Corporate Highlights

MIMOS and Technorad explore REVA for non-invasive blood testing

MIMOS met with Technorad Sdn Berhad looking into possibilities of utilising MIMOS’ latest technology, REVA, a Reagentless Vital Sign Analyser for non-intrusive blood testing and vital signs screening. It is a portable non-invasive haemoglobin meter with a vital signs analyser, with possible parameters including glucose, urea, and creatinine.

The meeting focused on exploring the possibilities of integrating REVA into Technorad’s product offerings or developing new applications based on this advanced technology.

This collaboration between MIMOS and Technorad has the potential to drive innovation and create new opportunities in the healthcare and medical technology sectors.